Novavax Inc. (United States) is listed on the Nasdaq and has a market capitalization of $1.29 billion, with shareholders equity totaling $-216.86 million.
The company employs approximately 791 people and operates in the Health Care sector, within the Biotechnology industry.
Over the past 12 months, Novavax Inc. reported $411.65 million in revenue, generating net income of $-76.73 million.
Key financial metrics include a P/E ratio of -16.82, a price-to-book (P/B) ratio of -5.95, and a trailing twelve-month dividend yield of 0.00%.
The company trades under the ticker NVAX.